Updated Feb. 18, 2013 at 6:32 a.m.

Premium Lock For GSK, other drug giants, pipelines rebound - and so do stocks

Published: 2013-02-18 06:26:00
Updated: 2013-02-18 06:32:48

GSK's R&D facility in RTP GSK's R&D facility in RTP. (GSK photo)

Pharmaceutical stocks of GlaxoSmithKline among others, which have soared in the past year to valuations not seen since 2001, are poised to extend their rally as investors grow more confident the industry has weathered a decade-long shortage of new drugs....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll